1. Dynamic cardiomyoplasty: at the crossroads
Michael A. Acker, MD 
The Annals of Thoracic Surgery 
Volume 68, Issue 2, Pages (August 1999)
DOI: /S (99)

2. Fig 1
Actuarial survival in Phase II multicenter clinical trial for dynamic cardiomyoplasty (DCMP): Comparison between patients having DCMP and matched reference group.
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

3. Fig 2
Long-term effects of cardiomyoplasty on cardiac function as seen in pressure–volume relationship. Ventricular pressure–volume loops and relations are shown for each patient at baseline (before cardiomyoplasty) and 1 year after operation. All patients demonstrated a reduction in chamber volume. Vertical arrows show initial end-diastolic volume. (DPVR = diastolic pressure–volume relationship; ESPVR = end-systolic pressure–volume relationship.) (Reproduced from Kass and associates [21] by permission of the American Heart Association.)
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

4. Fig 3
Design of Phase III randomized clinical trial, also known as C-SMART (Cardiomyoplasty–Skeletal Muscle Assist Randomized Trial).
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

5. Fig 4
Dynamic cardiomyoplasty probably acts by at least two mechanisms to ultimately limit the remodeling process of progressive heart failure.
The Annals of Thoracic Surgery  , DOI: ( /S (99) )